Literature DB >> 10193028

[Current treatment of closed injuries of the liver: benefits and pitfalls].

C Letoublon1, F Lachachi, C Arvieux, P Lavagne, H Amroun, P Delannoy, J L Faucheron.   

Abstract

STUDY AIM: The management of blunt hepatic trauma has been modified by the development of conservative methods. Risks and pitfalls of this new approach must be determined. PATIENTS AND METHODS: From January 1985 to September, 1998, 130 patients with blunt hepatic trauma were treated by the same team. Among them, 38 patients were referred from another centre (21 already having undergone operations). Eighty patients (61%) had an initial non operative management and 50 patients (39%) underwent emergency laparotomy. Perihepatic packing was performed in 24 patients, hepatic sutures in 22, limited hepatic resection in six, and major hepatectomy in two patients only.
RESULTS: There were three deaths in the non operative management group (mortality rate: 3.5%) and 11 patients required a secondary laparotomy: four for haemorrhage, one for enteric injury, two for acute pancreatitis, one for bile leakage, one for subphrenic abscess, one for acute cholecystitis. There were 14 deaths in the emergency laparotomy group (mortality rate: 28%), including four intraoperative deaths due to haemorrhage and two due to abdominal compartment syndrome.
CONCLUSIONS: In the nonoperative management group a close clinical survey of the patient is necessary and a secondary laparotomy often indicated. In the operative management group, early packing requires reintervention if the patient is unstable. Alternative means of temporary closure may allow coverage without tension in order to avoid the abdominal compartment syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10193028     DOI: 10.1016/s0001-4001(99)80038-5

Source DB:  PubMed          Journal:  Chirurgie        ISSN: 0001-4001


  1 in total

1.  Delayed celiotomy or laparoscopy as part of the nonoperative management of blunt hepatic trauma.

Authors:  Christian Letoublon; Yao Chen; Catherine Arvieux; David Voirin; Irene Morra; Christophe Broux; Olivier Risse
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.